XHEL
PIHLIS
Market cap266mUSD
Oct 09, Last price
10.62EUR
1D
1.53%
1Q
1.14%
Jan 2017
-42.35%
IPO
-17.55%
Name
Pihlajalinna Oyj
Chart & performance
P/E
6.35
P/S
0.37
EPS
1.67
Div yield, %
3.60%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
5.10%
Revenues
652m
-7.40%
Net income
38m
+37.43%
CFO
76m
-25.00%
Dividend
Apr 01, 20260.53 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Pihlajalinna Oyj provides social, healthcare, and wellbeing services to private persons, companies, insurance companies, and public sector entities in Finland. It operates in two segments, Private Healthcare Services and Public Services. The company offers general practitioner and medical specialist, occupational healthcare, social and healthcare outsourcing, fitness center, responsible doctor, and remote consultation services, as well as residential and staffing services. It also provides occupational health services to private clinics and hospitals, responsible doctor, diagnostics, and rehabilitation services. The company was founded in 2014 and is headquartered in Tampere, Finland.
Related entities
Subsidiaries (2)
Pihlajalinna Terveys Oy
Forever Helsinki Oy
Key people
Niclas Kohler
Chief Financial Officer · since 2016
Tarja Rantala
Chief Financial Officer · since 2019
Teija Kulmala
Chief Operating Officer · since 2019
Sanna Maattanen
Head of Service Development and Director of Digital Development (Chief Information Officer) · since 2019
Marko Savolainen
General Counsel · since 2018
Hannu Juvonen
Director · since 2019
Mika Manninen
Director · since 2019
Vice Chairman of the Board · since 2019
Kati Sulin
Director · since 2018
Legal address
PL 110
33101 TAMPERE
TAMPERE FI-33101
FI
33101 TAMPERE
TAMPERE FI-33101
FI
Headquarters
Kehräsaari B
33200 TAMPERE
TAMPERE FI-33200
FI
33200 TAMPERE
TAMPERE FI-33200
FI
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||